US Patent Issued to Albert Einstein College of Medicine on Jan. 27 for "KIR3DL3 is an inhibitory receptor of the immune system and uses thereof" (New York Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,527, issued on Jan. 27, was assigned to Albert Einstein College of Medicine (Bronx, N.Y.).

"KIR3DL3 is an inhibitory receptor of the immune system and uses thereof" was invented by Xingxing Zang (New York), Yao Wei (Larchmont, N.Y.), Xiaoxin Ren (Bronx, N.Y.) and Scott Moerdler (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are antibodies, immunogenic fragments and compositions thereof targeting the killer-cell immunoglobulin-like receptor protein KIR3DL3, as well as methods of using the same for the treatment of human diseases including cancer. In certain embodiments, the disclosure relates to an antibody or an immunogeni...